Pictured: Prasad Adusumilli
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, January 3, 2013

A team from Memorial Sloan Kettering has found that the makeup of immune cells in a lung tumor and in tissue surrounding a tumor can predict whether the cancer will recur after surgery.

Pictured: Diversity Programs
On Our Website
By Memorial Sloan Kettering  |  Monday, December 31, 2012

Our Office of Diversity Programs offers information and resources about clinical care, research, and training focused on reducing cancer health disparities in medically underserved populations.

Pictured: Richard Barakat
Video
By Memorial Sloan Kettering  |  Friday, December 28, 2012

Dr. Barakat explains the latest surgical techniques for improving outcomes and quality of life in women with cervical, ovarian, and other gynecologic cancers.

Pictured: Tim Ahles
Q&A
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, December 27, 2012

Problems with cognitive function can significantly impact a person’s quality of life after cancer treatment. New research is focused on the link between cancer treatment and cognitive changes.

Pictured: Marcel R. M. van den Brink
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Friday, December 21, 2012

Memorial Sloan Kettering researchers have shown for the first time that administering a growth factor called interleukin-7 can help patients regenerate T cells more quickly after stem cell transplantation.

Pictured: X-ray Image
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Wednesday, December 19, 2012

Scientists have identified genes and biological mechanisms that one day could be targeted with drugs to stop kidney cancer from spreading to the bone, brain, or other organs.

Pictured: Michel Sadelain
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, December 18, 2012

Memorial Sloan Kettering researchers have reported a new method that could allow the development of more-specific, cell-based therapies for cancer.

Pictured: Steven Wang
Q&A
By Andrea Peirce, BA, Writer/Editor  |  Monday, December 17, 2012

By mid-December 2012, sunscreen products on store shelves in the United States must meet stricter labeling regulations. Dr. Wang answers key questions on this topic.

Pictured: Ming Li
Q&A
By Eva Kiesler, PhD, Science Writer/Editor  |  Friday, December 14, 2012

Recent findings by Memorial Sloan Kettering immunologists might one day pave the way for new strategies to control a range of diseases, including autoimmune disorders and cancer.

Pictured: Michel Sadelain & Jedd Wolchok
Announcement
By Media Staff  |  Wednesday, December 12, 2012

Physician-scientists Michel Sadelain and Jedd Wolchok have been appointed to a new research team dedicated to investigating ways to harness the immune system to fight cancer.

Pictured: Lorenz Studer
Q&A
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, December 11, 2012

Methods to generate stem cells have given scientists new ways to study some diseases and identify potential drugs, and could one day be used to rebuild diseased or damaged tissues in patients.

Pictured: Ethel Law & Elizabeth Grahn
Announcement
By Media Staff  |  Monday, December 10, 2012

Memorial Sloan Kettering advanced practice nurses Elizabeth Grahn and Ethel Law have been recognized for their extraordinary achievements in education and research.

Pictured: Charles Sawyers
Announcement
By Media Staff  |  Saturday, December 8, 2012

Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is widely recognized as someone who is revolutionizing the molecular treatment of cancer.

Research
Pictured: Paul Chapman
Finding
By Memorial Sloan Kettering  |  Friday, December 7, 2012

Memorial Sloan Kettering experts add to their knowledge of vemurafenib, a drug recently approved by the FDA to treat some patients with metastatic melanoma.

Pictured: 2012 Rock Stars of Science
Announcement
By Allyson Collins, MS, Science Writer/Editor  |  Thursday, December 6, 2012

The initiative, focused on investigators from Memorial Sloan Kettering’s Geoffrey Beene Cancer Research Center, highlights the critical need for funding scientific research.

Center News

Stay Informed

Get the latest information about cancer care and research every month.